文献速递瓣膜外科

非切除性腱索折叠成形术治疗退行性二尖瓣反流的中期结局

Mid-term outcomes of non-resectional chordal foldoplasty for degenerative mitral regurgitation.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

本研究回顾性分析了2013年10月至2021年6月间82例因退行性二尖瓣病变伴高大后叶而接受非切除性腱索折叠成形术行二尖瓣修复的患者,评估手术结局、中期生存率、免于再手术率及免于复发中重度二尖瓣反流率。手术死亡为零,无转为二尖瓣置换,术后超声显示残余反流不超过轻度且无收缩期前向运动。5年生存率93.9%,免于二尖瓣再手术率97.4%,免于复发中重度二尖瓣反流率94.5%。作者认为该技术对选定伴高大后叶的退行性二尖瓣反流病例简单有效。

要点

  • 82例患者接受非切除性腱索折叠成形术,手术死亡为零,无转为二尖瓣置换。
  • 5年生存率93.9%,免于二尖瓣再手术率97.4%,免于复发中重度二尖瓣反流率94.5%。
  • 作者认为该技术对选定伴高大后叶的退行性二尖瓣反流病例简单有效。

核心结论

  • 非切除性腱索折叠成形术是治疗选定伴高大后叶的退行性二尖瓣反流病例的一种简单有效的修复技术。

研究设计与样本

  • 回顾性分析2013年10月至2021年6月间82例接受非切除性腱索折叠成形术行二尖瓣修复的退行性二尖瓣病变伴高大后叶患者。
  • 分析手术结局、中期生存率、免于再手术率和免于复发中重度二尖瓣反流率。

主要发现

  • 患者平均年龄57.2 ± 12.4岁;61例(74%)为后叶脱垂,21例(26%)为双叶脱垂,所有患者均有至少1个高大后叶扇贝。
  • 73例(89%)采用右侧小切口微创入路。
  • 手术死亡为零,无转为二尖瓣置换,术后超声显示残余反流不超过轻度且无收缩期前向运动。
  • 5年生存率为93.9%,免于二尖瓣再手术率为97.4%,免于复发中重度二尖瓣反流率为94.5%。

临床怎么用

  • 作者认为非切除性腱索折叠成形术对选定伴高大后叶的退行性二尖瓣反流病例是一种简单有效的修复技术。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to evaluate the mid-term clinical and echocardiographic outcomes of chordal foldoplasty performed for non-resectional mitral valve repair in degenerative mitral valve disease with a large posterior leaflet. METHODS: We reviewed 82 patients undergoing non-resectional mitral valve repair via chordal foldoplasty between October 2013 and June 2021. We analysed operative outcomes, mid-term survival rate, freedom from reoperation and freedom from recurrent moderate or severe mitral regurgitation (MR). RESULTS: The mean age of patients was 57.2 ± 12.4 years; 61 patients (74%) had posterior leaflet prolapse, 21 patients (26%) had bileaflet prolapse and all of them had at least 1 tall posterior leaflet scallop. Minimally invasive approach with a right mini-thoracotomy was used in 73 patients (89%). The operative mortality was zero. There was no conversion to mitral valve replacement and postoperative echocardiography revealed no more than mild residual regurgitation or systolic anterior motion. Five-year survival rate, freedom from mitral reoperation and freedom from recurrent moderate/severe MR were 93.9%, 97.4% and 94.5%, respectively. CONCLUSIONS: Non-resectional chordal foldoplasty is a simple and effective repair technique for select degenerative MR cases with a tall posterior leaflet.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Nakamura R, Nakanaga H, Fujii H, et al. Mid-term outcomes of non-resectional chordal foldoplasty for degenerative mitral regurgitation. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37233197. doi:10.1093/icvts/ivad084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。